T2 Biosystems (NASDAQ:TTOO) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note published on Friday morning. The brokerage issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Stock Performance

Shares of NASDAQ:TTOO opened at $0.06 on Friday. The firm has a 50 day moving average of $0.31 and a 200-day moving average of $1.47. T2 Biosystems has a 12 month low of $0.06 and a 12 month high of $6.95.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.